We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
+23.16%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$900K
AUM Growth
+$164K
Cap. Flow
+$54.9K
Cap. Flow %
6.11%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$54.9K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$949M
$793K 88.14%
36,747
+3,121
+9% +$54.9K
WHWK
2
Whitehawk Therapeutics
WHWK
$209M
$53.9K 5.99%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$52.8K 5.87%
13,727

Similar funds

ABG Innovation Capital Partners III's Q4 2023 Portfolio in Review

As of Q4 2023, ABG Innovation Capital Partners III held 3 positions worth $900K, up 22% from $736K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III deployed $54.9K of net new capital in Q4 2023, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III added most to Castle Biosciences in Q4 2023, an estimated $54.9K increase.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $900K portfolio in Q4 2023.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q4 2023.
  • ABG Innovation Capital Partners III's portfolio value rose 22% quarter-over-quarter to $900K.

Based on ABG Innovation Capital Partners III's 13F filing for Q4 2023, filed 14 Feb 2024.